Director received an award of 7,415 MRNA derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 8, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 10, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001682852-26-000139
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personMichael R. Mcdonnell SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateJul 8, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- This option will become fully vested and exercisable on July 8, 2027.